It has certainly paid off for us continuing to hold on to our high equity allocation throughout the semester and not entering into any timing-driven sales or purchases. Equally, the waiver of any costly hedging exercises contributed positively to the overall portfolio performance.
At its meetings, the Investment Committee decided on the following changes to the asset allocation for medium-risk balanced Swiss Franc portfolios, not subject to client’s restrictions (mandates in different reference currencies at times display different nominal weightings and weighting changes).
“All Quiet on the Western Front”, one is inclined to say with a view to money markets. As we did not make any changes to the overall weighting of any asset class, the money market allocation too remained unchanged. Cash is slightly above its long term strategic target allocation serving as an opportunistic reserve. In addition, it is a worthwhile buffer against value fluctuations in other asset classes.
Bond markets in developed industrial nations are a gigantic drought zone. The sum of all bonds trading at negative yields continued to rise, reaching a new high of 13 trillion US Dollars (a 13 followed by 12 zeros). In the past twelve months alone, this amount has doubled, according to the “Neue Zürcher Zeitung” (NZZ). Bonds with negative yields to maturity are a phenomenon unknown prior to the financial crisis. Needless to say, we, as well as our clients, are suffering from thirst in this drought zone.
Other funds employed by us developed as follows:
We remain unchanged neutral weight Swiss stocks. The directly invested “Swiss Stock Portfolio” (SSP) achieved a performance of 16.2% during the first half of the year. The Swiss Performance Index (SPI) came in with 21.8% and with it, ranks among the top performers of the semester. Only Athens’ (39.6%) and Moscow’s (28.2%) performance looked more spectacular from a Swiss Franc perspective. Since 2012, the average annual performance of the SSP, typically comprised of about 20 stocks, amounts to 15.8%, a result that clearly beats the average benchmark’s performance of 11.4%
Since 2012, the total cumulative return of this strategy amounts to about 200%, while that of the index to 124%. The SSP figures bear transaction costs, whereas the benchmark index does not bear any costs. The “Strategy Certificate linked to the SIM Swiss Stock Portfolio Basket” (Valor: 36524524, ISIN: CH0365245247) achieved a performance of 15% during the first six months of the year.
The second quarter saw the annual rebalancing take place. In the process, the most attractive names of the Swiss market are either added, or remain in the portfolio, whereas the least attractive ones are sold. At the same time, all stocks with the exception of Nestlé, Novartis and Roche are rebalanced to equal weight. The three heavyweights of the index are newly also overweight in this selection. We have given them a double weighting.
New to the portfolio are the stocks of Helvetia, Swatch, Swisscom and Ypsomed, whereas Bobst, Feintool, Vifor Pharma, as well as Zurich Insurance, have had to make room. Adecco, Also, Autoneum and Vetropack remain in the selection of fundamentally attractive stocks. The same goes for the consumer stocks of Bell Food, Metall Zug, Nestlé and Orior. While Swiss Life, Baloise and Cembra Bank represent the financial sector, and the pharmaceuticals and health industry by Coltene, Novartis, Roche, Siegfried, as well as Sonova. These adjustments apply equally to the direct investments in clients’ portfolios as well as the composition of the certificate.
Since the beginning of the year, yields on 10-year government bonds declined across the board:
European equities also underwent their rebalancing. New amongst the most attractively valued stocks are Randstad and SKF, the Italian utility A2A, as well as the consumer stocks Persimmon and British American Tobacco. The technology sector is newly covered by the German companies Siltronic and Software AG, as well as the French Sopra Steria Group. As the most attractive financial stocks, Jupiter Fund Management and CNP Assurances are now part of this selection consisting of 25 names. The chemicals and pharmaceuticals sector is represented by the Belgian UCB and the British Hikma Pharmaceuticals.
Repsol, Saras, Aurubis and Babcock International held on to their places. Amsterdam Commodities, Tate & Lyle, Barratt Developments, as well as Renault, also remain aboard. Amongst the financials, Legal & General as well as Nordea Bank asserted their position, as did Fresenius Medical, Arkema and Covestro in the chemical and pharmaceutical sector. As part of these adjustments, all names in the portfolio were put on equal weights again.
Price/Book and Dividend Yield of major equity markets:
The Dow Jones Stoxx 600 Index achieved a total return (price change plus dividends) of 16.5%. This put our stock selection behind. The directly invested “European Stock Portfolio” (ESP) achieved 6.9%.
We see the following reasons for this: Firstly, value style investing generally underperformed growth style investing these past months. Secondly, stocks of small and mid-capitalised companies rose less than those of the large “battleships” contained in the benchmark. In the past, however, the addition of small to medium-sized companies proved a valuable contributor to the long-term outperformance of the ESP vis-à-vis the reference index.
The third reason is to be found in an unusual cluster of unfavourable, company-specific factors. Companies in sectors such as automotive, financials, chemicals and commodities have in part been punished excessively as their business performance was affected by the trade war, suffered from the decline in oil, copper and other raw material prices, or were affected by the British Pound’s weakness following Theresa May’s resignation.
Long term, the ESP selection’s outperformance remains intact. Since 1993, the ESP has returned on average 8.2% compared to the 6.9% achieved by the Dow Jones Stoxx 600 Index. The transaction costs, as well as taxes withheld, are deducted in ESP figures, whereas the index is calculated without bearing any costs. The cumulative performance of the ESP since 1993 amounts to above 769%, while that of the benchmark to about 527%.
American stocks did things in style, as the six months’ return of the MSCI Total Return USA with a plus of 18.4% illustrates. The Performa US Equities Fund employed by us even outshone this, with its performance of 25.5%. At 17%, the sector specific BB Adamant Medtech and Services Fund also returned well into the double digits. We did not make any changes to the US stock weighting and with it, maintained its slight overweight position.
Measured on the price/earnings ratio using the latest 12 months profit figures, most equity markets have become more expensive:
Equities Asia (excluding Japan)
Asian equities were not getting anywhere during the second quarter. For the half year, the index performance amounts to 10.7%, the Aberdeen Asia Pacific (ex Japan) Fund employed by us even managed 13.5%. No changes were made to the Asian allocation during the reporting period.
During the second quarter, the rising sun was nowhere to be seen in Japan. Quotes were plodding along, and bottom line, the level of the leading index dropped off marginally. For the first half of the year, at least a performance of 5.8% remained in the index, the same as for the CHF and Euro hedged share classes of the equity fund employed by us. We are neutral weight Japanese equities, which from a fundamental point of view are amongst the most attractively valued.
There was a slight positive for the global Hedge Fund Index in US Dollar, taking the half year’s performance just over 4%. The instruments employed by us in this sector managed a better harvest across the board (in US Dollar). Even the Euro and Swiss Franc hedged share classes employed by us managed to come in on top of this. We have not made any changes to the positions.
Gold rose to new splendour in the second quarter. The precious metal broke out of its year-long sideways price range. In June, it reached 1420 US Dollar at times, a level not seen since August 2013. Quotes were driven by increased political tensions in the Middle East, a weakening US Dollar and receding interest rates. With interest rates low, investors give up less when holding non-productive gold instead of interest bearing bonds. During times of high interest rates, this opportunity loss argues against the precious metal.
Upon the close of the G-20 summit (renewed dialogue between USA and China) and the handshake between Donald Trump and Kim Jong Un at the Korean internal border, gold gave up some of the gains just towards the end of the quarter, but still managed to carry a double digit increase across the finishing line. We have not made any changes to our position during the reporting period.
Summary of our current Asset Allocation: